Medtronic (MDT) DIvidends Date & History

Key Takeaways

• Medtronic (MDT) pays a quarterly dividend of $0.72 per share, or $2.88 annually, for a dividend yield of roughly 3.2%.
• The company has raised its dividend for 49 consecutive years, putting it one year away from reaching coveted "Dividend King" status and making it a member of the S&P 500 Dividend Aristocrats.
• Dividend growth has been steady but modest, with a five-year compound annual growth rate (CAGR) of about 4% and a 1.4% increase in the most recent hike.
• Payout ratios remain manageable, with roughly 71% of trailing earnings and a lower share of free cash flow distributed as dividends.
• The stock's yield is well above the broader market and most medical-device peers, appealing primarily to income-focused and long-term dividend investors.

Dividend Overview

Medtronic plc (MDT), the global medical-technology leader, maintains a well-established, quarterly dividend policy. The company currently pays $0.72 per share each quarter, which equates to an annualized dividend of $2.88 per share. Based on recent share prices, that translates to a dividend yield of approximately 3.2% — a level notably higher than the average yield of the S&P 500 and more than three times the broader market's typical payout.

Medtronic is best classified as a dividend growth stock rather than a pure high-yield name. Its yield sits comfortably above most large-cap healthcare peers, yet its true appeal lies in its extraordinary consistency: the company has increased its dividend every year for nearly five decades. Payments are made quarterly, providing shareholders with a steady, predictable income stream backed by a diversified portfolio of cardiac, diabetes, surgical, and neuroscience products.

Dividend History and Growth

Medtronic's dividend record is among the most durable in the healthcare sector. The company has now increased its per-share dividend for 49 consecutive years, a track record that places it on the verge of joining the elite group of "Dividend Kings" — companies with at least 50 straight years of increases. Medtronic is also a long-standing member of the S&P 500 Dividend Aristocrats, an index of companies that have raised payouts for at least 25 years.

Growth has been deliberate rather than aggressive. Over the past five years, the dividend has compounded at roughly 4% annually, with longer-term rates of about 6% over ten years and 11% over twenty years, according to the company's investor relations data. The most recent increase raised the quarterly payout from $0.71 to $0.72 per share, a modest 1.4% step-up. This pattern reflects management's preference for consistent, sustainable increases rather than large, cyclical jumps.

Dividend Sustainability and Payout Ratio

Medtronic's dividend appears reasonably well-covered by both earnings and cash flow. The company currently pays out roughly 71% of trailing earnings as dividends, according to recent data. On a forward-looking basis, that figure declines to the high-40s to mid-40s percentage range, suggesting improving earnings coverage as the business recovers. Notably, Medtronic has strengthened its free cash flow, which has helped lower the payout burden on a cash-flow basis to a more conservative level near 38% to 59%, depending on the measure used.

This profile indicates the dividend is sustainable, though the near-term growth rate is limited by a relatively elevated earnings-based payout ratio. Medtronic's scale, diversified revenue base, and steady operating cash generation provide an additional cushion. Investors should, however, monitor the company's debt levels and any prolonged pressure on earnings growth, as those factors ultimately determine the headroom for future increases.

Dividend Compared to Industry Peers

Within the medical-device and diversified healthcare space, Medtronic's yield stands out. Its roughly 3.2% dividend yield exceeds that of most direct competitors, including Abbott Laboratories (ABT), Stryker (SYK), and Becton Dickinson (BDX), each of which yields between roughly 1% and 2%. Boston Scientific (BSX) pays no dividend at all, choosing instead to reinvest fully in growth.

Medtronic's payout is more closely aligned with diversified healthcare giant Johnson & Johnson (JNJ), which also offers a yield in the low-3% range. In short, among large-cap medical-device peers, Medtronic provides one of the higher and more dependable dividend income streams, making it a relative standout for yield-oriented investors within the sector.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is especially useful for identifying dividend stocks, income-focused investments, trending stocks, and breakout candidates far more efficiently than manual screening. Whether you are searching for reliable dividend payers like Medtronic or exploring new market opportunities, the AI Screener can help streamline your research process.

Is This Stock Attractive for Dividend Investors?

Medtronic is likely to appeal most to income-oriented and long-term dividend growth investors who prioritize reliability and a track record of consistent payouts over rapid increases. Its near-3.2% yield and 49-year growth streak offer a rare combination of current income and historical dependability. Conservative investors seeking steady cash flow with moderate risk may also find the company's diversified medical-device business and strong free cash flow reassuring.

That said, the recent pace of dividend growth has been modest — around 1.4% in the latest increase — which may be less compelling for investors who demand aggressive payout growth. A relatively elevated earnings-based payout ratio also leaves limited immediate room for large hikes. As a result, Medtronic is best suited for those who value stability, a meaningful starting yield, and the prospect of continued, if gradual, annual increases, rather than investors chasing rapid dividend expansion or maximum yield.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations